(BR) Broadridge Financial - Overview
Stock: Proxy, Communications, Trade Processing, Compliance, Outsourcing
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.56% |
| Yield on Cost 5y | 2.82% |
| Yield CAGR 5y | 11.16% |
| Payout Consistency | 100.0% |
| Payout Ratio | 49.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 45.0% |
| Relative Tail Risk | -5.16% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.15 |
| Alpha | -33.55 |
| Character TTM | |
|---|---|
| Beta | 0.556 |
| Beta Downside | 0.590 |
| Drawdowns 3y | |
|---|---|
| Max DD | 31.28% |
| CAGR/Max DD | 0.30 |
Description: BR Broadridge Financial December 17, 2025
Broadridge Financial Solutions (NYSE:BR) delivers investor communications and technology-driven workflow automation to banks, broker-dealers, corporate issuers, and fund managers worldwide, operating through two primary segments: Investor Communication Solutions and Global Technology & Operations.
The Investor Communication Solutions segment manages proxy material distribution, electronic voting (via ProxyEdge), regulatory filings, and omni-channel content delivery, while also providing mutual fund and ETF trade processing, data-analytics, and registrar services. In FY 2023 the segment generated roughly $2.8 billion in revenue, reflecting a 7% year-over-year increase driven by heightened demand for digital proxy voting and SEC filing automation.
The Global Technology & Operations segment automates the front-to-back lifecycle of equities, fixed income, FX, and derivatives, offering services such as trade confirmation, margin and cash management, reference-data reconciliation, and compliance reporting. This segment posted about $1.9 billion in FY 2023 revenue, with operating margins expanding to 31% as clients adopt end-to-end cloud solutions to reduce operational costs.
Key industry drivers include rising regulatory complexity (e.g., ESG disclosure requirements), accelerated fintech adoption, and the shift toward cloud-based, real-time processing-trends that position Broadridge to capture incremental market share. For a deeper dive into the valuation nuances, you might explore ValueRay’s detailed model.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 925.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 4.21 > 1.0 |
| NWC/Revenue: -1.63% < 20% (prev 5.81%; Δ -7.44% < -1%) |
| CFO/TA 0.16 > 3% & CFO 1.34b > Net Income 925.1m |
| Net Debt (3.19b) to EBITDA (1.67b): 1.91 < 3 |
| Current Ratio: 0.93 > 1.5 & < 3 |
| Outstanding Shares: last quarter (118.0m) vs 12m ago -0.08% < -2% |
| Gross Margin: 31.34% > 18% (prev 0.30%; Δ 3105 % > 0.5%) |
| Asset Turnover: 86.47% > 50% (prev 81.06%; Δ 5.41% > 0%) |
| Interest Coverage Ratio: 10.44 > 6 (EBITDA TTM 1.67b / Interest Expense TTM 124.1m) |
Altman Z'' 3.20
| A: -0.01 (Total Current Assets 1.46b - Total Current Liabilities 1.57b) / Total Assets 8.30b |
| B: 0.47 (Retained Earnings 3.93b / Total Assets 8.30b) |
| C: 0.16 (EBIT TTM 1.30b / Avg Total Assets 8.16b) |
| D: 0.65 (Book Value of Equity 3.69b / Total Liabilities 5.67b) |
| Altman-Z'' Score: 3.20 = A |
Beneish M -3.09
| DSRI: 0.99 (Receivables 963.7m/895.3m, Revenue 7.06b/6.50b) |
| GMI: 0.95 (GM 31.34% / 29.64%) |
| AQI: 0.97 (AQ_t 0.78 / AQ_t-1 0.81) |
| SGI: 1.09 (Revenue 7.06b / 6.50b) |
| TATA: -0.05 (NI 925.1m - CFO 1.34b) / TA 8.30b) |
| Beneish M-Score: -3.09 (Cap -4..+1) = AA |
What is the price of BR shares?
Over the past week, the price has changed by -7.71%, over one month by -17.95%, over three months by -16.01% and over the past year by -23.01%.
Is BR a buy, sell or hold?
- StrongBuy: 0
- Buy: 5
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 267.9 | 47.3% |
| Analysts Target Price | 267.9 | 47.3% |
| ValueRay Target Price | 179.2 | -1.5% |
BR Fundamental Data Overview February 04, 2026
P/E Forward = 20.8333
P/S = 3.2813
P/B = 8.6802
P/EG = 1.5674
Revenue TTM = 7.06b USD
EBIT TTM = 1.30b USD
EBITDA TTM = 1.67b USD
Long Term Debt = 2.78b USD (from longTermDebt, last quarter)
Short Term Debt = 537.6m USD (from shortTermDebt, last quarter)
Debt = 3.48b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.19b USD (from netDebt column, last quarter)
Enterprise Value = 26.34b USD (23.15b + Debt 3.48b - CCE 290.7m)
Interest Coverage Ratio = 10.44 (Ebit TTM 1.30b / Interest Expense TTM 124.1m)
EV/FCF = 20.79x (Enterprise Value 26.34b / FCF TTM 1.27b)
FCF Yield = 4.81% (FCF TTM 1.27b / Enterprise Value 26.34b)
FCF Margin = 17.96% (FCF TTM 1.27b / Revenue TTM 7.06b)
Net Margin = 13.11% (Net Income TTM 925.1m / Revenue TTM 7.06b)
Gross Margin = 31.34% ((Revenue TTM 7.06b - Cost of Revenue TTM 4.84b) / Revenue TTM)
Gross Margin QoQ = 26.59% (prev 37.27%)
Tobins Q-Ratio = 3.17 (Enterprise Value 26.34b / Total Assets 8.30b)
Interest Expense / Debt = 0.70% (Interest Expense 24.2m / Debt 3.48b)
Taxrate = 22.38% (47.7m / 213.1m)
NOPAT = 1.01b (EBIT 1.30b * (1 - 22.38%))
Current Ratio = 0.93 (Total Current Assets 1.46b / Total Current Liabilities 1.57b)
Debt / Equity = 1.32 (Debt 3.48b / totalStockholderEquity, last quarter 2.64b)
Debt / EBITDA = 1.91 (Net Debt 3.19b / EBITDA 1.67b)
Debt / FCF = 2.52 (Net Debt 3.19b / FCF TTM 1.27b)
Total Stockholder Equity = 2.44b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.34% (Net Income 925.1m / Total Assets 8.30b)
RoE = 37.96% (Net Income TTM 925.1m / Total Stockholder Equity 2.44b)
RoCE = 24.82% (EBIT 1.30b / Capital Employed (Equity 2.44b + L.T.Debt 2.78b))
RoIC = 17.10% (NOPAT 1.01b / Invested Capital 5.88b)
WACC = 6.99% (E(23.15b)/V(26.63b) * Re(7.96%) + D(3.48b)/V(26.63b) * Rd(0.70%) * (1-Tc(0.22)))
Discount Rate = 7.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.46%
[DCF Debug] Terminal Value 84.62% ; FCFF base≈1.11b ; Y1≈1.38b ; Y5≈2.34b
Fair Price DCF = 398.1 (EV 49.66b - Net Debt 3.19b = Equity 46.48b / Shares 116.7m; r=6.99% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 15.76 | EPS CAGR: -5.04% | SUE: 2.71 | # QB: 3
Revenue Correlation: 51.55 | Revenue CAGR: 6.40% | SUE: 1.25 | # QB: 1
EPS next Quarter (2026-03-31): EPS=2.71 | Chg30d=-0.001 | Revisions Net=-1 | Analysts=8
EPS current Year (2026-06-30): EPS=9.45 | Chg30d=+0.002 | Revisions Net=-1 | Growth EPS=+10.5% | Growth Revenue=+5.5%
EPS next Year (2027-06-30): EPS=10.27 | Chg30d=+0.001 | Revisions Net=-1 | Growth EPS=+8.7% | Growth Revenue=+4.9%